Cancer Smart Pills Market Size (2023-2030)

The Global Cancer Smart Pills Market was estimated to be worth USD 1.3 Billion in 2022 and is anticipated to reach a value of USD 2.07 Billion by 2030, growing at a fast CAGR of 6% during the forecast period 2023-2030.

Cancer smart pills are cancer-targeting systems that are designed specifically to minimize the growth of cancer cells and ensure a healthy life for people. These smart pills incorporate various components, which include nanoparticles, antibodies, targeting agents, and others. Further, they help in recognizing specific characteristics found in cancer cells and hence help in targeting and controlling their unusual growth. One of the major benefits of cancer smart pills is that once it finds the targeted tumor or cancer cell, it directly releases medication to control it. This medication includes chemotherapy drugs that minimize the exposure of the tumor to other parts of the body such as tissues and thereby reduce the risk of cancer. Furthermore, these pills provide real-time monitoring through sensors and imaging agents that enable health practitioners to monitor tumor growth and alter the treatment as per the need. Furthermore, cancer smart pills are still in the developmental stages and require extensive research and clinical trials to ensure their efficiency, drug release mechanisms, and safety for patients. Moreover, the increasing prevalence of cancers in recent years is predicted to boost the market for cancer smart pills.

Global Cancer Smart Pills Market Drivers:

Increasing the prevalence of cancer to boost the cancer smart pills market.

Cancer is a global health concern and therefore researchers and scientists are making constant efforts in eliminating its risks in the body. The increasing burden of cancer presses the urgent need to have an effective and targeted treatment facility that ensures overall safety for people across the globe. Further, the most common cancer types are breast cancer, lung cancer, colon, rectum, and prostate cancer. Moreover, as per WHO (World Health Organization), cancer is the leading cause of death and accounted for 10 million deaths in 2020. Additionally, the most common cases were breast cancer, accounting for 2.26 million. Cancer smart pills can become a potential solution for treating cancer through improved drug delivery systems. Further, conventional cancer treatments such as chemotherapy affected both the cancer and healthy cells affecting the quality of life of patients. By contrast, cancer smart pills can target specific cancer cells and minimize the spread of it to other parts of the body. Moreover, sensors are encapsulated with oral chemotherapy drugs that allow health professionals to monitor patients and their health status effectively.

Technological advancements in medical science drive the market for smart pills.

Integration of technology with medical science has benefitted patients and helped in the reduction of potential disease risks. These include developments in the field of nanotechnology, imaging, and sensor technology that helped to develop cancer smart pills. Further, nanoparticles have emerged as a potential solution for drug delivery as they possess specific properties that help in targeting specific cancer cells. Moreover, their small size allows them to easily enter the body and search for the tumor site. Furthermore, imaging technology has provided numerous benefits to health professionals. Imaging agents are incorporated in cancer smart pills that enable health professionals to visualize the tumor and monitor the drug delivery progress in real-time. Further, sensor-encapsulated pills help in detecting the changes in pH level, oxygen level, and specific changes in the patient’s body that help health professionals in making better treatment decisions. For instance, Proteus digital cancer chemotherapy pill is embedded with sensors and activates the stomach acid. Further, it sends an electronic signal before getting dissolved into the patient’s body. Moreover, it also allows health professionals to monitor the treatment progress via the company’s mobile platform.

Global Cancer Smart Pills Market Challenges:

Safety and toxicity can hamper the market growth of cancer smart pills. Though cancer smart pills aim to reduce the growth of cancer cells and minimize damage to healthy cells, they can cause serious side effects if not implemented properly. This includes the uncontrolled release of kinetic drugs from cancer smart pills that can harm the tissues and healthy organs of the patient’s body.

Furthermore, prolonged exposure to monitoring in the patient’s body can have side effects, and therefore safety monitoring along with controlled drug delivery is essential for the growth of cancer smart pills in the market.

Global Cancer Smart Pills Market Opportunities:

The Global Cancer Smart Pills Market is anticipated to deliver lucrative opportunities for businesses, which include acquisitions, partnerships, collaborations, product launches, and agreements during the forecasted period. Furthermore, owing to the increase in demand for healthy products and tasty flavors such as coconut and maple is predicted to develop the market for Cancer Smart Pills and enhance its future growth opportunities.

COVID-19 Impact on the Global Cancer Smart Pills Market:

The pandemic hurt the cancer smart pills market. Due to the lockdown and shifted focus toward combating virus mutation, there was a delay in clinical trials of cancer smart pills. Moreover, due to shifted focus toward novel virus infections and the treatment of patients, there was a scarcity of technological, physical, and human resources such as healthcare professionals, researchers, scientists, doctors, medical equipment, and others. Further, the reallocation of healthcare budgets towards the pandemic and treatment of patients neglected the development of cancer smart pills and affected its market growth.

Global Cancer Smart Pills Market Recent Developments:

No recent developments found on the internet.

CANCER SMART PILLS MARKET REPORT COVERAGE:

Global Cancer Smart Pills Market Segmentation: By Cancer Type

• Breast Cancer

• Lung Cancer

• Colorectal Cancer

• Prostate Cancer

• Other

Based on market segmentation by cancer type, breast cancer occupies the highest share in the market. Breast cancer is among the common types of cancer cases in women, which if not treated properly can lead to the death of the patient. Cancer smart pills can target breast cancer cells and deliver chemotherapy or targeted therapies to minimize the risk and improve the patient’s quality of life. Moreover, it helps in tumour shrinkage and reduces the potential risks of cancer development. The colorectal cancer segment occupies a significant share of the market. It is a type of cancer that develops in the colon or rectum of the body. Cancer smart pills can incorporate controlled drug release that ensures that the drug reached the tumour site and minimizes damage to healthy tissues by targeted therapy to the colon cancer cells. The prostate cancer segment occupies a sizeable market share and is common cancer found in men. Cancer smart pills can target the receptors present in prostate cancer cells by targeting agents such as antibodies, peptides, ligands, or others that can prevent potential risks to it. Furthermore, the incorporation of targeted therapies such as immunotherapies, androgen receptor inhibitors, precision medicines, and others help in directly impacting the cancer cell.

Global Cancer Smart Pills Market Segmentation: By End-User

• Hospitals

• Clinics & Oncology Centers

• Research Institute

• Pharmaceuticals

• Others

Based on market segmentation by end-user, hospitals occupy the largest share of the market. Hospitals are the major user of cancer smart pills as it helps them in detailed diagnosis, treatment, and management of cancer-affected patients. The research institute segment occupies a significant share of the market. Research institutes help in the development and advancement of cancer smart pills. Further, these pills and advanced technology help them to run clinical trials and optimize the drug formulations for efficient cancer treatment. The pharmaceutical segment is the fastest-growing segment during the forecast period. Pharmaceuticals play an essential role in developing, manufacturing, and distributing cancer smart pills to healthcare professionals and consumers, thereby contributing to mitigating the potential risks of cancer.

Global Cancer Smart Pills Market Segmentation: By Region

• North America

• Europe

• Asia Pacific

• Middle East and Africa

• South America

Based on market segmentation by region, North America occupies the highest share of the market. The high prevalence of cancer and the contribution of research institutes in developing cancer smart pills fuel the market growth for cancer smart pills in the region. As per CDC (Centers For Disease Control & Prevention), nearly 1,603,844 new cancer cases were reported in the USA in 2020. Moreover, the most common type of cancer in the region is breast and lung cancer. This is increasing the demand for efficient treatment mechanisms to reduce cancer risks. Furthermore, due to established research and development institutes' constant efforts in the field of cancer, cancer smart pills have witnessed an increase in demand in the region. For instance, a team led by Canadian University of Saskatchewan researcher Dr Khan Wahid has been working since 2020 in developing an AI sensor-enabled smart pill gut imaging device to diagnose gastrointestinal cancer and bleeding that can provide improved diagnostic accuracy to health professionals.

Asia-Pacific is the fastest-growing region during the forecast period. Increased support from the government in the form of investments and healthcare expenditure for improved healthcare infrastructure and technology is fuelling the demand for cancer smart pills in the region.

Global Cancer Smart Pills Market Key Players:

1. Proteus Digital Health

2. Medtronic

3. Olympus Corporation

4. CapsoVision

5. Check-Cap Ltd

6. IntroMedic

7. Jinshan Science & Technology